ArticleOncology reports2025

Thermal cycling‑hyperthermia sensitizes non‑small cell lung cancer A549 cells to EGFR tyrosine kinase inhibitor erlotinib.

Guan-Bo Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.